Hilo Health key facts
as of Oct 2026- Developer of a monitoring tool designed to prevent and assist in high blood pressure.
- Hilo Health is valued at approximately $45.2M as of Oct 2026 (last reported valuation).
- It has raised $111.8M; the latest was Later Stage VC ($42.0M) in May 2025.
- Notable investors include Khosla Ventures, Verve Ventures, Earlybird Venture Capital, Molten Ventures, KFund — 19 tracked in total.
- Status: Privately Held (backing).
Hilo Health's last reported valuation, Jun 2023. Nothing priced has surfaced since.
- ·The complete investor list: 19 names
- ·Watch Hilo Health: the Monday email on marks, rounds and moves
Hilo Health funding rounds
No funding rounds for Hilo Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Hilo Health
19+Membership and data by Private Market View
Hilo Health valuation
Hilo Health's last reported valuation was $45.2 million in Jun 2023. No priced round, secondary trade or fund mark has surfaced since.
Hilo Health investors
19 investors are on record for Hilo Health, including Khosla Ventures, Verve Ventures, Earlybird Venture Capital and Molten Ventures. By type, the record holds 7 venture capital firms.
About Hilo Health
Developer of a monitoring tool designed to prevent and assist in high blood pressure. The company's tool combines common optical sensors and clinically validated software algorithms to measure an individual's blood pressure at the wrist, enabling patients to understand the underlying causes of blood pressure to develop new approaches to deal with the limiting and life-threatening condition.
- Sector
- Healthcare
- HQ
- Neuchatel, Switzerland
- Founded
- 2018
- Employees
- 76
- Website
- hilo.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.